Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Sankyo isolates A-76356, novel antibacterial agent

Nov. 19, 1997

MiKasome enters phase II for UTI

Nov. 18, 1997

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Nov. 18, 1997

Inhibitors of viral neuraminidase from Biota

Nov. 17, 1997

Xoma reports phase II results of Neuprex in trauma patients

Nov. 14, 1997

Cubist acquires rights to daptomycin

Nov. 13, 1997

Suntory's penems are active against MRSA

Nov. 13, 1997

SKB to fund antiinfective research at Australian university

Nov. 12, 1997

Pola's newest antifungal agents disclosed in patent literature

Nov. 12, 1997

ArQule, ViroPharma to collaborate on antiviral drugs

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...